Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
BIIB
BIIB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BIIB News
Biogen Unveils New Research Data on Spinal Muscular Atrophy
5d ago
Newsfilter
Stoke and Biogen Release Zorevunersen Study Data
5d ago
NASDAQ.COM
Zorevunersen Shows Promise for Dravet Syndrome Treatment
5d ago
Newsfilter
Market Dynamics and Investment Opportunities Analysis
Feb 20 2026
CNBC
Biogen Elects New Chair of the Board
Feb 11 2026
Newsfilter
Biogen Elects Dr. Maria C. Freire as New Chair of the Board
Feb 11 2026
Yahoo Finance
Biogen Reports Q4 and Full Year 2025 Earnings Exceeding Expectations
Feb 09 2026
Newsfilter
Biogen Reports Better-Than-Expected Q4 Results
Feb 09 2026
Benzinga
Biogen Reports Strong Q4 Earnings, Beats Expectations
Feb 09 2026
Benzinga
Wall Street Analysts Adjust Ratings
Feb 09 2026
Benzinga
China Grants Priority Review for Biogen and Eisai's Alzheimer's Treatment
Feb 09 2026
stocktwits
LEQEMBI® Receives Priority Review in China
Feb 09 2026
Newsfilter
LEQEMBI® Receives Priority Review in China
Feb 09 2026
Yahoo Finance
Biogen's 2025 Financials Exceed Expectations
Feb 08 2026
NASDAQ.COM
Biogen Reports 2025 Earnings Exceeding Expectations
Feb 07 2026
Fool
Biogen Inc. Reports Strong Q4 2025 Earnings with Growth Products Driving Revenue
Feb 06 2026
seekingalpha
Show More News
